Literature DB >> 20888411

Codrug: an efficient approach for drug optimization.

N Das1, M Dhanawat, B Dash, R C Nagarwal, S K Shrivastava.   

Abstract

Codrug or mutual prodrug is an approach where various effective drugs, which are associated with some drawbacks, can be modified by attaching with other drugs of same or different categories directly or via a linkage. More appropriately one can say combining two different pharmacophores with similar or different pharmacological activities elicit synergistic action or help to target the parent drug to specific site/organ/cells respectively. This approach is commonly used to improve physicochemical, biopharmaceutical and drug delivery properties of therapeutic agents.
Copyright © 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20888411     DOI: 10.1016/j.ejps.2010.09.014

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  15 in total

Review 1.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

Review 2.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

Review 3.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

Review 4.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

Review 5.  Targeting Toxins toward Tumors.

Authors:  Henrik Franzyk; Søren Brøgger Christensen
Journal:  Molecules       Date:  2021-02-27       Impact factor: 4.411

Review 6.  Recent advances in the treatment of neurodegenerative diseases based on GSH delivery systems.

Authors:  Ivana Cacciatore; Leonardo Baldassarre; Erika Fornasari; Adriano Mollica; Francesco Pinnen
Journal:  Oxid Med Cell Longev       Date:  2012-06-03       Impact factor: 6.543

7.  In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist-neurokinin 1 receptor antagonist chimera.

Authors:  Karel Guillemyn; Patrycja Kleczkowska; Alexandre Novoa; Bart Vandormael; Isabelle Van den Eynde; Piotr Kosson; Muhammad Faheem Asim; Peter W Schiller; Mariana Spetea; Andrzej W Lipkowski; Dirk Tourwé; Steven Ballet
Journal:  Mol Brain       Date:  2012-01-30       Impact factor: 4.041

8.  Carvacrol codrugs: a new approach in the antimicrobial plan.

Authors:  Ivana Cacciatore; Mara Di Giulio; Erika Fornasari; Antonio Di Stefano; Laura Serafina Cerasa; Lisa Marinelli; Hasan Turkez; Emanuela Di Campli; Soraya Di Bartolomeo; Iole Robuffo; Luigina Cellini
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

Review 9.  Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.

Authors:  Amjad M Qandil
Journal:  Int J Mol Sci       Date:  2012-12-17       Impact factor: 5.923

Review 10.  Molecular Consortia-Various Structural and Synthetic Concepts for More Effective Therapeutics Synthesis.

Authors:  Anna Pawełczyk; Katarzyna Sowa-Kasprzak; Dorota Olender; Lucjusz Zaprutko
Journal:  Int J Mol Sci       Date:  2018-04-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.